Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Prostate Cancer
100%
Bladder Cancer
59%
Bladder
54%
Cystectomy
39%
Non Muscle Invasive Bladder Cancer
37%
Diseases
30%
Malignant Neoplasm
28%
Biopsy Technique
27%
Transitional Cell Carcinoma
27%
Urothelial Cancer
25%
Androgen Deprivation Therapy
25%
Metastatic Carcinoma
25%
Randomized Controlled Trial
25%
Urology
24%
Quality of Life
24%
Radiation Therapy
23%
Prospective Cohort Study
22%
Prostate Biopsy
22%
Transrectal Ultrasonography
22%
Tumor
22%
Cancer
19%
Microhematuria
19%
Durvalumab
19%
Prostate Specific Antigen
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Mycobacterium Bovis BCG
17%
Pelvis
15%
Positron Emission Tomography-Computed Tomography
15%
COVID-19
15%
Infection
15%
Disease Exacerbation
14%
Computer Assisted Tomography
13%
Polyethylene Terephthalate
13%
Recurrent Disease
13%
Muscle Invasive Bladder Cancer
12%
Immunotherapy
12%
Clear Cell Renal Cell Carcinoma
12%
Prostatectomy
12%
Arm
12%
Patient Referral
12%
Intravesical Drug Administration
11%
Cancer Surgery
11%
Medicine
11%
Clinical Trial
11%
Colic
11%
Orchiectomy
10%
Adverse Event
10%
Placebo
10%
Conservative Treatment
10%
Kidney Injury
10%
Pharmacology, Toxicology and Pharmaceutical Science
Non Muscle Invasive Bladder Cancer
35%
Bladder Cancer
27%
Prostate Cancer
18%
Durvalumab
14%
Diseases
11%
Androgen
11%
Recurrent Disease
11%
Mycobacterium Bovis BCG
10%
Muscle Invasive Bladder Cancer
10%
Malignant Neoplasm
10%
Clinical Trial
10%
SARS Coronavirus
9%
Prospective Cohort Study
9%
Transitional Cell Carcinoma
9%
Mitomycin
9%
Chemotherapy
7%
Adverse Event
7%
Tolerability
6%
Prevalence
5%
Infection
5%
Biological Marker
5%
Immune Checkpoint Inhibitor
5%
Prostate Specific Antigen
5%
Leuprorelin
5%
Nursing and Health Professions
Prostate Cancer
46%
Androgen Deprivation Therapy
15%
Fat Mass
10%
Systematic Review
9%
Bladder Cancer
9%
Prostatectomy
9%
Muscle Strength
8%
Patient Referral
8%
Body Composition
8%
Prostate Specific Antigen
7%
Confidence Interval
7%
Cancer Incidence
7%
Surgeon
6%
Severe Acute Respiratory Syndrome
6%
Surgical Mortality
5%
Prospective Cohort Study
5%
Odds Ratio
5%
Cancer Survival
5%